We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00177554
Recruitment Status : Completed
First Posted : September 15, 2005
Last Update Posted : May 29, 2008
Sponsor:
Collaborator:
Biogen
Information provided by:
University of Pittsburgh